MARK L PERRY Insider Trading
Get free email notifications about insider trading for MARK L PERRY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK L PERRY. MARK L PERRY is a Director in ARCA biopharma, Inc. ($ABIO) and a Director in NVIDIA CORP ($NVDA) and a Director in MyoKardia Inc ($MYOK) and a Director in Global Blood Therapeutics, Inc. ($GBT).
Address: C/O NUVELO, INC. 675 ALMANOR AVENUE SUNNYVALE 94085 CA
Companies in which MARK L PERRY is an Insider
ARCA biopharma, Inc.
Trading Symbol: ABIOIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of MARK L PERRY: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 26 2005
$ABIO Market Capitalization: $23.40M
$ABIO Previous Close: $2.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Global Blood Therapeutics, Inc.
Trading Symbol: GBTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK L PERRY: Director
Holdings: 31,228 shares
Current Value: $505,894
Latest Transaction: Jun 19 2020
$GBT Market Capitalization: $626.91M
$GBT Previous Close: $16.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MyoKardia, Inc.
Trading Symbol: MYOKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK L PERRY: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 19 2020
$MYOK Market Capitalization: $375.56M
$MYOK Previous Close: $12.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NVIDIA CORP
Trading Symbol: NVDAIndustry: SEMICONDUCTORS & RELATED DEVICES [3674]
Position of MARK L PERRY: Director
Holdings: 8,031 shares
Current Value: $956,733
Latest Transaction: Apr 06 2021
$NVDA Market Capitalization: $63.93B
$NVDA Previous Close: $119.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MARK L PERRY
Sentiment: All, ABIO, GBT, MYOK, NVDA
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 06 2021 | NVDA | NVIDIA CORP | PERRY MARK L | Director | Sell | S | 556.98 | 1,400 | 779,772 | 6,631 | 8 K to 6.6 K (-17.43 %) |
Apr 06 2021 | NVDA | NVIDIA CORP | PERRY MARK L | Director | Sell | S | 556.46 | 4,704 | 2,617,588 | 8,031 | 12.7 K to 8 K (-36.94 %) |
Nov 19 2020 | MYOK | MyoKardia, Inc. | PERRY MARK L | Director | Option Exercise | D | 100.27 | 3,000 | 300,810 | 0 | |
Nov 19 2020 | MYOK | MyoKardia, Inc. | PERRY MARK L | Director | Option Exercise | D | 47.77 | 6,600 | 315,282 | 0 | |
Nov 19 2020 | MYOK | MyoKardia, Inc. | PERRY MARK L | Director | Option Exercise | D | 48.85 | 11,000 | 537,350 | 0 | |
Nov 19 2020 | MYOK | MyoKardia, Inc. | PERRY MARK L | Director | Option Exercise | D | 14.00 | 11,000 | 154,000 | 0 | |
Nov 19 2020 | MYOK | MyoKardia, Inc. | PERRY MARK L | Director | Option Exercise | D | 13.60 | 11,000 | 149,600 | 0 |